Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-β/activin/nodal signalling inhibition
Mariann Koel(Karolinska Institutet), Andres Salumets(Karolinska University Hospital), Elísabet Einarsdóttir(University of Helsinki), Ulf‐Håkan Stenman(University of Helsinki), Timo Tuuri(University of Helsinki), Urmo Võsa(University Medical Center Groningen), Sulev Ingerpuu(University of Tartu), Shintaro Katayama(Karolinska Institutet), Karolina Lundin(University of Helsinki), Viljar Jaks(Tartu University Hospital), Juha S. Tapanainen(University of Oulu), Juha Kere(University of Helsinki), Kaarel Krjutškov(Karolinska Institutet)
Cited by 14
Related Papers
Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
|Nature Genetics|2021|2.2k
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
|Nature Genetics|2019|1.6k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
Gene co-expression analysis for functional classification and gene–disease predictions
|Briefings in Bioinformatics|2016|1.1k
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis
|Nature Biotechnology|2013|1k